Pitfalls of hepatitis E

Size: px
Start display at page:

Download "Pitfalls of hepatitis E"

Transcription

1 Pitfalls of hepatitis E Antwerp, October 18th 2016 prof.dr. Hans L. Zaaijer MD PhD, medical microbiologist Sanquin Blood Supply Foundation & Academic Medical Centre, Amsterdam NL Disclosure of interests of Hans Zaaijer - No conflicts of interests. - Links to commercial partners: Hans Zaaijer is or was paid by ACTA, Abbott, Gilead, Griffols, ISBT, Janssen-Cilag, Roche, Virology Education for unrestricted lectures and teaching. - No consultancy, no shares or other interests in companies. 1

2 pitfall #1 'hepatitis E' does not exist: 2 separate disease entities, caused by different pathogens R.H. Purcell, aangepast Zaaijer 2

3 R.H. Purcell #1 hepatitis E = 2 disease entities HEV genotype 1 human to human HEV genotype 3 pig to human pregnant women 20% fatality no disease children acute hepatitis no disease adults acute hepatitis #1 no disease #2? sporadic: neuralgic amyotrophy middle aged, elderly acute hepatitis acute hepatitis (mild) #3 organ/sc Tx patients? chronic hepatitis, cirrhosis #4 GBS? GBS? 3

4 #1 21x acute hep E in NL ( ) among returning travellers: m 38 Pakistan m 28 Bangladesh m 30 Bangladesh m 34 Bangladesh m 38 India v 35 India m 36 India m 26 India v 23 India v 29 India m 32 India m 34 India v 24 India (fulminant, recovered) v 34 India (fulminant, 2x liver-tx) m 59 China (fulminant, liver-tx, ) m 28 Soedan m 40 Somalie m 32 Midden Oosten m 48 Aruba m 20 NL: Breezand v 45 NL: Amsterdam #2: silent HEV gt3 infection in Dutch donors Monthly HEV PCR screening of Dutch plasmapools of 96: Overall ( ) : 79/101,793 = 1/1289 HEV RNA+ Incidence: 1% / yr 4

5 : 4067 samples submitted for 'hep.serology' : 144 HEV-IgM and PCR pos. > questionnaire > 81 responses: #3: 52 Dutch hep E patients, no travel or immune sup./def. Koot ea, J.Clin.Virol #4: hepatitis E in solid organ and in allogeneic stem cell transplant patients, caused by HEV gt3 5

6 pitfall #2 chronic hepatitis E in: - solid organ transplant patients and - allogeneic stem cell transplant patients often mistaken for: - drug induced liver injury ('dili') - graft versus host disease of the liver rapidly causing liver cirrhosis case 1: mr. A, 51 yrs diagnosis de Niet ea. Neth. J. Med. 2012; 70:

7 case 2: boy B, now 10 yrs of age 2006: severe pneumococcal infection HUS kidney Tx 2011: chronic hepatitis eci, 'drug induced liver injury' (dili)? diagnosis Bouts ea. Pediatrics 2015 step 1 = mycophenolate mofetil: 800 to 600 mg/m2/day step 2 = tacrolimus: 0.1 to 0.05 mg/kg/day (prednisolone remained unmodified at 2 mg/m2/day) case 3: mrs. C, 55 yrs 7

8 pitfall #3 patients with immuno suppression or immuno deficiency: diagnosis of acute and chronic hep E must be based on HEV RNA PCR, do not use serology serology often is negative during infection (including improved, modern HEV Ab EIAs) case 4: mr. D, 67 yrs - CLL, anti-cd20 chronic hep E without antibody response: IgG and IgM anti-hev negative (Wantai EIA) 8

9 pitfall #4 avoid relapse after ribavirin treatment of chronic hep E: continue ribavirin 2 or 3 months after plasma HEV PCR became negative (or 1 month after feces HEV PCR = neg?) case 5: mr.e, 60 yrs. 2006: CLL: allo-sct, 2014 relapse, chemo 9

10 sources and transmission of HEV genotype 3 adapted from: WHM vd Poel - Current Opinion in Virology 2014, 4:

11 Sanquin project L1965: transmission of HEV After fruitless testing of raw sausages, vegetables, etc, by HEV PCR: Leverworst: Paté s: 43 / 55 (78%) PCR+ 12 / 15 (80%) PCR+ confirmed by NVWA (Dutch Food Safety Authority) dietary advice for organ- and allo-sc Tx patients. mmm: Mettbrötchen! 11

12 pitfall #5 phylogeny of HEV gt3: sequencing of ORF1 and ORF2 does not provide sufficient genetic resolution to study HEV genotype 3c dynamics in EU patients, pigs, blood donors and food. > sequencing of hyper variable region? (dendogram not yet available for public domain) Summary of HEV pitfalls - 'Hepatitis E' refers to 2 distinct diseases: tropical human-to-human hepatitis by HEV genotypes 1/2, and endemic-zoonotic hepatitis by HEV genotypes 3/4. - Beware of chronic HEV gt3 infection in organ transplant patients and hematological patients, - which may remain seronegative during years. In these patients test for hep E using HEV PCR, not IgG/IgM serology. (in immuno competent persons, modern IgG/IgM HEV serology is okay for diagnosis of acute tropical or acute endemic hep E). - Response to ribavirin treatment of hep E: do not stop ribavirin too early. - Phylogeny of EU strains of HEV subgenotype 3c : insufficient resolution of common HEV RNA sequencing. 12

13 HEV team at Sanquin: Boris Hogema Michel Molier Hans Zaaijer Anneke de Vos Mart Janssen H.L.Zaaijer, 2016, Amsterdam, NL not to be copied or distributed without written consent of H.L.Zaaijer. 13

Hepatitis E virus genotype 3 : what we know so far

Hepatitis E virus genotype 3 : what we know so far Hepatitis E virus genotype 3 : what we know so far May 20 th, 2015 Hans L. Zaaijer MD PhD Sanquin - Blood-borne Infections & Academic Medical Centre - Clinical Virology Amsterdam NL HEV gt 3: the issues

More information

Hepatitis E Virus Infection. Disclosures

Hepatitis E Virus Infection. Disclosures Hepatitis E Virus Infection Simona Rossi, MD Associate Chair, Division of Hepatology Einstein Medical Center Philadelphia Consultant for BMS Speaker for Gilead Disclosures I have no conflicts to report

More information

New recommendations for immunocompromised patients

New recommendations for immunocompromised patients New recommendations for immunocompromised patients Hepatitis E Virus (HEV): Transmission, incidence and presentation Emerging evidence regarding HEV transmission from blood components and dietary consumption

More information

Chronic Hepatitis E Resolved by Reduced Immunosuppression in Pediatric Kidney Transplant Patients

Chronic Hepatitis E Resolved by Reduced Immunosuppression in Pediatric Kidney Transplant Patients Chronic Hepatitis E Resolved by Reduced Immunosuppression in Pediatric Kidney Transplant Patients Antonia H.M. Bouts, MD, PhD a, Pytrik J. Schriemer, MD a, Hans L. Zaaijer, MD, PhD b,c At present, transient

More information

Epidemiology of HAV, HDV and HEV in Belgium

Epidemiology of HAV, HDV and HEV in Belgium Epidemiology of HAV, HDV and HEV in Belgium Prof. Dr. Steven Van Gucht National Reference Centre of Hepatitis Viruses B, C, D and E Viral Diseases Scientific Institute of Public Health (WIV-ISP) Brussels

More information

Epidemiological profiles of viral hepatitis in Italy Effects of migration

Epidemiological profiles of viral hepatitis in Italy Effects of migration Epidemiological profiles of viral hepatitis in Italy Effects of migration Hepatitis A and E T. Santantonio UOC di Malattie Infettive Università degli Studi di Foggia Azienda Ospedaliero-Universitaria Ospedali

More information

Hepa%%s E Virus Is it a Concern?

Hepa%%s E Virus Is it a Concern? IPFA/PEI 17 th Workshop on Surveillance and Screening of Blood Borne Pathogens 26-27 May 2010, The Regent Esplanade Zagreb Hotel, Zagreb, Croa%a Hepa%%s E Virus Is it a Concern? Keiji Matsubayashi Hokkaido

More information

HEPATITIS E. Enterically transmitted zoonotic RNA virus in the genus Hepevirus 7200 bases 3 ORFs

HEPATITIS E. Enterically transmitted zoonotic RNA virus in the genus Hepevirus 7200 bases 3 ORFs HEPATITIS E and HIV Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Case Presentation A 54 yo man with HBV/HIV

More information

Hepatitis E and the English blood supply

Hepatitis E and the English blood supply Hepatitis E and the English blood supply Mhairi Webster Microbiology Senior Scientist National Transfusion Microbiology Reference Laboratory With thanks to Dr Alan Kitchen Hepatitis E virus Small, non-enveloped

More information

Hepatitis E in South Africa. Tongai Maponga

Hepatitis E in South Africa. Tongai Maponga Hepatitis E in South Africa Tongai Maponga 7th FIDSSA CONGRESS 2017 This is what usually comes to mind History of hepatitis E virus An ET-NANB hepatitis virus later named HEV was first suspected in 1980.

More information

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science

Uses and Misuses of Viral Hepatitis Testing. Origins of Liver Science Uses and Misuses of Viral Hepatitis Testing Richard S Lang, MD, MPH, FACP Chairman, Preventive Medicine Vice-Chair, Wellness Institute Raul J Seballos, MD, FACP Vice-Chair, Preventive Medicine Wellness

More information

Hepatitis E in humans. Alfredo Pérez (Hospital 12 de Octubre, Madrid. Spain)

Hepatitis E in humans. Alfredo Pérez (Hospital 12 de Octubre, Madrid. Spain) Hepatitis E in humans Alfredo Pérez (Hospital 12 de Octubre, Madrid. Spain) VIRAL HEPATITIS Those caused by different viruses with primary tropism for the liver tissue History (discovery) Hepatitis A Hepatitis

More information

Is it the time to start blood screening for Hepatitis-E?

Is it the time to start blood screening for Hepatitis-E? Is it the time to start blood screening for Hepatitis-E? Dr. Somnath Mukherjee MD, MAMS Assistant Professor All India Institute of Medical Sciences Bhubaneswar During last 25 years the safety of blood

More information

Hepatitis E FAQs for Health Professionals

Hepatitis E FAQs for Health Professionals Hepatitis E FAQs for Health Professionals Index of Questions ± Overview and Statistics What is Hepatitis E? How common is Hepatitis E in the United States? Where is Hepatitis E most common? Are there different

More information

The ABC s (and D & E s) of the Viral Hepatitides Part 2 DIAGNOSTIC TESTS 3/7/2013

The ABC s (and D & E s) of the Viral Hepatitides Part 2 DIAGNOSTIC TESTS 3/7/2013 The ABC s (and D & E s) of the Viral Hepatitides Part 2 Thomas Novicki PhD DABMM Clinical Microbiologist Division of Laboratory Medicine novicki.thomas@marshfieldclinic.org Objectives 2 1. Explain the

More information

Hepatitis E Virus Update December 2014

Hepatitis E Virus Update December 2014 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel 604.707.2400 Fax 604.707.2516 www.bccdc.ca Hepatitis E Virus Update December 2014 What is hepatitis E Virus? Hepatitis E Virus (HEV) was first identified

More information

Update on Transfusion- Transmitted Infectious Diseases

Update on Transfusion- Transmitted Infectious Diseases Update on Transfusion- Transmitted Infectious Diseases Scott Koepsell MD PhD Associate Professor University of Nebraska Medical Center I have no conflicts of interest to disclose. Global changes and the

More information

Health care associated viral hepatitis in the Netherlands

Health care associated viral hepatitis in the Netherlands Health care associated viral hepatitis in the Netherlands VHPB, nov 14th, 2008 session 6: prevention and control Hans L. Zaaijer, medical microbiologist AMC Clinical Virology / Sanquin - Blood-borne infections

More information

HEV Update Blood Components. Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden)

HEV Update Blood Components. Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden) HEV Update Blood Components Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden) Outline ECDC activities started in 2015 to understand the epidemiology and burden of HEV infection

More information

Infective hepatic complications in HSCT patients. Simone Cesaro. Pediatric Hematology Oncology Verona, Italy. Session II: organ specific complications

Infective hepatic complications in HSCT patients. Simone Cesaro. Pediatric Hematology Oncology Verona, Italy. Session II: organ specific complications Session II: organ specific complications Infective hepatic complications in HSCT patients Simone Cesaro Pediatric Hematology Oncology Verona, Italy simone.cesaro@ospedaleuniverona.it Liver complications

More information

Transfusion transmission of hepatitis E virus: an emerging issue

Transfusion transmission of hepatitis E virus: an emerging issue Review Article Page 1 of 7 Transfusion transmission of hepatitis E virus: an emerging issue Kenrad E. Nelson Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore,

More information

Hepatitis A and Hepatitis E

Hepatitis A and Hepatitis E Hepatitis A and Hepatitis E Luis S. Marsano, MD Professor of Medicine Division of Gastroenterology, Hepatology & Nutrition University of Louisville and Louisville VAMC 2011 Viruses that cause Hepatitis

More information

Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/

Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/ www.pei.de Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/09.2126 S. Baylis, Division of Virology, Paul-Ehrlich-Institut, Langen, Germany SoGAT XXII 14 th -15 th April 2011, Rome, Italy Presented at:

More information

Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici

Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici Il trapianto di cellule staminali emopoietiche nel paziente portatore di virus epatitici Anna Locasciulli Ematologia e Trapianto di Cellule Staminali Emopoietiche Ospedale S.Camillo, Roma Il trapianto

More information

Detection of IgA-class anti-hev antibody

Detection of IgA-class anti-hev antibody Detection of IgA-class anti-hev antibody Hiroaki OKAMOTO E IgA-HE IgA HEV E HEV E E E 10 E 1997 E E 1, 2 2001 E 3 HEV 4 1979 HEV 5 A B C A B C E 6, 7 E HEV E 8 11 2003 8 19 http:www.mhlw. go.jphoudou200308h0819-2.html

More information

Kalliopi Azariadi, Pinelopi Arvaniti, Nikolaos Gatselis, George N. Dalekos, Kalliopi Zachou

Kalliopi Azariadi, Pinelopi Arvaniti, Nikolaos Gatselis, George N. Dalekos, Kalliopi Zachou Severe acute non-a, non-b, non-c hepatitis with autoimmune features: Consider acute hepatitis E virus (HEV) infection not just autoimmune hepatitis (AIH) Kalliopi Azariadi, Pinelopi Arvaniti, Nikolaos

More information

Epidemiology of hepatitis E infection in Hong Kong

Epidemiology of hepatitis E infection in Hong Kong RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epidemiology of hepatitis E infection in Hong Kong DPC Chan *, KCK Lee, SS Lee K e y M e s s a g e s 1. The overall anti hepatitis E virus (HEV) seropositivity

More information

Summary of Key Points WHO Position Paper on Vaccines against Hepatitis E Virus(HEV) May 2015

Summary of Key Points WHO Position Paper on Vaccines against Hepatitis E Virus(HEV) May 2015 Summary of Key Points WHO Position Paper on Vaccines against Hepatitis E Virus(HEV) May 2015 1 Background l Hepatitis E Virus (HEV): leading cause of acute viral hepatitis in developing countries. l Genotypes

More information

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a Viral hepatitis Supervised by: Dr.Gaith presented by: Shaima a & Anas & Ala a Etiology Common: Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Less common: Cytomegalovirus EBV Rare: Herpes

More information

Current concepts in hepatitis E. Does it exist in Greece?

Current concepts in hepatitis E. Does it exist in Greece? Current concepts in hepatitis E. Does it exist in Greece? Nikolaos K. Gatselis Department of Medicine and Research Lab of Internal Medicine Larissa Medical School Thessaly University Discovery of Hepatitis

More information

The ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses

The ABCs of Viral Hepatitis Diagnosis. Ila Singh, M.D., Ph.D. P & S Viral Hepatitis. Hepatitis A, B, C, D, E and G viruses The ABCs of Viral Hepatitis Diagnosis Ila Singh, M.D., Ph.D. P & S 14-453 is132@columbia.edu Viral Hepatitis Hepatotropic viruses Hepatitis A, B, C, D, E and G viruses Generalized infection plus infection

More information

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses. Learning Objectives: Hepatitis Update ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Upon attendance of this seminar and review of material provided, the attendees will be able to: 1. List hepatitis viruses

More information

Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa

Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa Kim et al. BMC Infectious Diseases (2017) 17:187 DOI 10.1186/s12879-017-2274-3 ERRATUM Erratum to: A systematic review of the epidemiology of hepatitis E virus in Africa Open Access Jong-Hoon Kim 1*, Kenrad

More information

Transmission of HEV by plasmapheresis. Vincent Mallet, MD, PhD CHU Cochin, Université Paris Descartes, APHP, Inserm

Transmission of HEV by plasmapheresis. Vincent Mallet, MD, PhD CHU Cochin, Université Paris Descartes, APHP, Inserm Transmission of HEV by plasmapheresis Vincent Mallet, MD, PhD CHU Cochin, Université Paris Descartes, APHP, Inserm Transmission of HEV by secured plasma Transmission of HEV by plasma IA Transmission of

More information

Anticipating (re)emerging infections to ensure blood safety

Anticipating (re)emerging infections to ensure blood safety Anticipating (re)emerging infections to ensure blood safety Pierre Tiberghien Etablissement Français du Sang, St-Denis and Université de Franche-Comté, Besançon, France IPFA/PEI 23rd International Workshop

More information

Hepatitis E virus in Israel

Hepatitis E virus in Israel Hepatitis E virus in Israel Daniela Ram 1, Yossi Manor 1, Yael Gozlan 1, Rachel Shirazi 1, Eli Schwartz 2,3, Ziv Ben-Ari 3,4, Ella Mendelson 1,5, Pozzi Shaul 6, Orna Mor 1 1 Central Virology Laboratory,

More information

Viral Hepatitis Diagnosis and Management

Viral Hepatitis Diagnosis and Management Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents

More information

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV

E E Hepatitis E SARS 29, Lancet. E A B Enterically-Transmitted Non-A, Hepatitis E. Virus HEV nm. 1.35g/cm s ALT AST HEV HEV 7850 2004 Hepatitis E Tian-Cheng LI Naokazu TAKEDA Tatsuo MIYAMURA SARS 8 Lancet E E E Hepatitis E VirusHEV E E HEV HEV E 1955 29,000 E E A A B Enterically-Transmitted Non-A, Non-B Hepatitis 1983 Balayan

More information

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL

Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL Clinical Management of Hepatitis B WAN-CHENG CHOW DEPARTMENT OF GASTROENTEROLOGY & HEPATOLOGY SINGAPORE GENERAL HOSPITAL The World Health Organisation recent initiatives on HBV infection Launching of the

More information

Hepatitis E: When to think about? How to treat? Heiner Wedemeyer

Hepatitis E: When to think about? How to treat? Heiner Wedemeyer Hepatitis E: When to think about? How to treat? Heiner Wedemeyer August 26 2016 Is hepatitis E really a problem? Numbers The Disease Pathogenesis Treatment Hepatitis E - Waterborne hepatitis, first described

More information

keyword: hepatitis Hepatitis

keyword: hepatitis Hepatitis www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,

More information

Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017

Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017 Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017 S. Rod Rassekh Pediatric Oncologist BC Children s Hospital Objectives Discuss the immune system and vaccination

More information

Hepatitis A-E Viruses. Dr Nemes Zsuzsanna

Hepatitis A-E Viruses. Dr Nemes Zsuzsanna Hepatitis A-E Viruses Dr Nemes Zsuzsanna Viral Hepatitis - Historical Perspectives Infectious A E Enterically transmitted Viral hepatitis NANB Serum B D C Parenterally transmitted HGV, TTV, SEN, other

More information

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust

Dr David Rowbotham NHS. The Leeds Teaching Hospitals. NHS Trust Dr David Rowbotham The Leeds Teaching Hospitals NHS Trust NHS Nurses Update June 2010 Chronic Hepatitis HBV / HCV David Rowbotham Clinical Director & Consultant Gastroenterologist Dept of Gastroenterology

More information

Hepatitis E in developing countries

Hepatitis E in developing countries Hepatitis E in developing countries Hepatitis E in developing countries Rakesh Aggarwal Department of Gastroenterology Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Forms Epidemic

More information

DISCLOSURES RELEVANT TO THIS PRESENTATION NONE. Off label use of drugs will be discussed

DISCLOSURES RELEVANT TO THIS PRESENTATION NONE. Off label use of drugs will be discussed Hepatitis E in HIV Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine DISCLOSURES RELEVANT TO THIS NONE PRESENTATION

More information

Evaluation of run controls for cobas 6800 MPX and HEV assay

Evaluation of run controls for cobas 6800 MPX and HEV assay Evaluation of run controls for cobas 6800 MPX and HEV assay Marco Koppelman Head of Nucleic Acid testing (NAT) laboratory, National Screening laboratory of Sanquin (NSS) in the Netherlands Satellite Meeting

More information

Risk of Infection when travelling South. Liège Crowne Plaza 19/11/2016

Risk of Infection when travelling South. Liège Crowne Plaza 19/11/2016 Risk of Infection when travelling South Filipom Klik Moerman, de ondertitelstijl Infectiologist. van het model te bewerken Liège Crowne Plaza 19/11/2016 Strongyloides Middle East respiratory syndrome

More information

Cases: CMV, HCV, BKV and Kidney Transplantation. Simin Goral, MD University of Pennsylvania Medical Center

Cases: CMV, HCV, BKV and Kidney Transplantation. Simin Goral, MD University of Pennsylvania Medical Center Cases: CMV, HCV, BKV and Kidney Transplantation Simin Goral, MD University of Pennsylvania Medical Center Disclosures Grant support: Otsuka Pharmaceuticals, Astellas Pharma, Angion, AstraZeneca, and Kadmon

More information

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob: Hepatitis Dr. Mohamed. A. Mahdi Mob: 0123002800 5/2/2019 Hepatitis Hepatitis means the inflammation of the liver. May cause by viruses or bacteria, parasites, radiation, drugs, chemical and toxins (alcohol).

More information

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC) HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC

More information

DIFFERENTIAL BENEFITS OF DAAs IN DIFFERENT PATIENT POPULATIONS. IN PATIENTS ON A WAITING LIST FOR TRANSPLANTATION. THE CLINIC.

DIFFERENTIAL BENEFITS OF DAAs IN DIFFERENT PATIENT POPULATIONS. IN PATIENTS ON A WAITING LIST FOR TRANSPLANTATION. THE CLINIC. DIFFERENTIAL BENEFITS OF DAAs IN DIFFERENT PATIENT POPULATIONS. IN PATIENTS ON A WAITING LIST FOR TRANSPLANTATION. THE CLINIC. Robert J. de Knegt, Erasmus MC, Rotterdam r.deknegt@erasmusmc.nl Disclosures

More information

Transplantation (Hematopoietic Stem Cell Transplantation (HSCT)) Immunization Recommendations

Transplantation (Hematopoietic Stem Cell Transplantation (HSCT)) Immunization Recommendations Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique 5850/5980 University Avenue, PO Box 9700, Halifax, NS, B3K 6R8, 1.902.470.7429,

More information

Update on Hepatitis B and Hepatitis C

Update on Hepatitis B and Hepatitis C Update on Hepatitis B and Hepatitis C Catherine Stedman Department of Gastroenterology, Christchurch Hospital and University of Otago, Christchurch Disclosures I have the following financial relationships

More information

Thirty years of harm reduction in the Netherlands HCV elimination ahead?

Thirty years of harm reduction in the Netherlands HCV elimination ahead? Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther

More information

Viral Hepatitis. Dr. Abdulwahhab S. Abdullah CABM, FICMS-G&H PROF. DR. SABEHA ALBAYATI CABM,FRCP

Viral Hepatitis. Dr. Abdulwahhab S. Abdullah CABM, FICMS-G&H PROF. DR. SABEHA ALBAYATI CABM,FRCP Viral Hepatitis Dr. Abdulwahhab S. Abdullah CABM, FICMS-G&H PROF. DR. SABEHA ALBAYATI CABM,FRCP Viral hepatitis Viral hepatitis must be considered in any patient presenting with hepatitis on LFTs (high

More information

Hepatitis E virus (HEV) in England was previously

Hepatitis E virus (HEV) in England was previously ORIGINAL RESEARCH Virology, serology, and demography of hepatitis E viremic blood donors in South East England Richard S. Tedder, 1,2,3 Kate I. Tettmar, 1,2 Su R. Brailsford, 1,4 Bengu Said, 5 Ines Ushiro-Lumb,

More information

HEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis)

HEPATITIS VIRUSES. Other causes (not exclusively hepatitis v.)also called sporadic hepatitis: HEPATITIS A(infectious hepatitis) Dept.of Microbiology/Virology Assist.prof. Shatha F. Abdullah HEPATITIS VIRUSES Medically important hepatitis v. (liver)are: 1.HAV 2.HBV 3.HCV 4.HDV 5.HEV 6.HGV Other causes (not exclusively hepatitis

More information

Update of hepa++s E in Hong Kong. Dr Chow Chi Wing Department of Medicine Tseung Kwan O Hospital

Update of hepa++s E in Hong Kong. Dr Chow Chi Wing Department of Medicine Tseung Kwan O Hospital Update of hepa++s E in Hong Kong Dr Chow Chi Wing Department of Medicine Tseung Kwan O Hospital HEV: The History Probably causing human disease for centuries Iden+fied on EM by Dr Balayan in 1983 Viral

More information

Hépatite E & transplantation d organes Pr Nassim KAMAR

Hépatite E & transplantation d organes Pr Nassim KAMAR Hépatite E & transplantation d organes Pr Nassim KAMAR Service de Néphrologie, Dialyse et Transplantation d Organes CHU Rangueil- Toulouse Genotype 3 HEV infection is an emerging disease in developing

More information

A national multidisciplinary healthcare network for treatment of hepatitis C in PWID in Slovenia Prof. Mojca Matičič, MD, PhD

A national multidisciplinary healthcare network for treatment of hepatitis C in PWID in Slovenia Prof. Mojca Matičič, MD, PhD A national multidisciplinary healthcare network for treatment of hepatitis C in PWID in Slovenia Prof. Mojca Matičič, MD, PhD Clinic for Infectious Diseases and Febrile Illnesses University Medical Centre

More information

Hepatitis E Epidemie in NL. Joost PH Drenth Department of Gastroenterology and Hepatology, Radboudumc Nijmegen, The Netherlands 28 november 2018

Hepatitis E Epidemie in NL. Joost PH Drenth Department of Gastroenterology and Hepatology, Radboudumc Nijmegen, The Netherlands 28 november 2018 Hepatitis E Epidemie in NL Joost PH Drenth Department of Gastroenterology and Hepatology, Radboudumc Nijmegen, The Netherlands 28 november 2018 Disclosure of Conflicts of Interest I herewith declare the

More information

Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening

Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening Amena Ahmad, Ralf Reintjes Hamburg University of Applied Sciences, Germany European Conference on Migrant and Ethnic

More information

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route

More information

Lecture-7- Hazem Al-Khafaji 2016

Lecture-7- Hazem Al-Khafaji 2016 TOXOPLASMOSIS Lecture-7- Hazem Al-Khafaji 2016 TOXOPLASMOSIS It is a disease caused by Toxoplasma gondii which is a protozoan parasite that is infects a variety of mammals and birds throughout the world.

More information

EBV Protocol

EBV Protocol EBV Protocol 8.26.14 Data From UNOS Summary Stats 1988-2014 CASU + 2009-2014 CAPC Organ Total PTLD Percent PTLD Percent PTLD in Literature Heart 294 21 7 3-9 Heart-Lung 34 3 9 16 Intestine 42 7 17 10-45

More information

Chronic Hepatitis. Andrew Bathgate Chris Bellamy Royal Infirmary of Edinburgh

Chronic Hepatitis. Andrew Bathgate Chris Bellamy Royal Infirmary of Edinburgh Chronic Hepatitis Andrew Bathgate Chris Bellamy Royal Infirmary of Edinburgh Autoimmune Hepatitis Annual incidence 1.9/100 000 in N Europe Prevalence 16.9/100 000 ~5% all liver transplants Female preponderance

More information

Hepatitis E Jacques Izopet Federative Institute of Biology & INSERM U1043 Toulouse University - France

Hepatitis E Jacques Izopet Federative Institute of Biology & INSERM U1043 Toulouse University - France IPFA/PEI 19th International Workshop on Surveillance and Screening of Blood Borne Pathogens Budapest 23-24 May 2012 Hepatitis E Jacques Izopet Federative Institute of Biology & INSERM U1043 Toulouse University

More information

Hepatitis E virus control in the pig reservoir

Hepatitis E virus control in the pig reservoir Hepatitis E virus control in the pig reservoir Wim H. M. van der Poel June 2018 Wageningen University Wageningen Bioveterinary Research Wageningen BioVeterinary Research Lelystad Wageningen University

More information

Viral Hepatitis in Reproductive Health

Viral Hepatitis in Reproductive Health Viral Hepatitis in Reproductive Health Training Course in Sexual and Reproductive Health Research Geneva 2010 Dr José M Bengoa Dr Pierre Jean Malè Consultants Division of Gastroenterology and Hepatology

More information

Detection of HEV in Estonia. Anna Ivanova, Irina Golovljova, Valentina Tefanova

Detection of HEV in Estonia. Anna Ivanova, Irina Golovljova, Valentina Tefanova Detection of HEV in Estonia Anna Ivanova, Irina Golovljova, Valentina Tefanova National Institute for Health Development Department of Virology Zoonotic pathogens Tick-borne pathogens: TBEV, Borrelia sp.,

More information

Hepatitis D. Challenges in 2018

Hepatitis D. Challenges in 2018 Hepatitis D Challenges in 2018 Heiner Wedemeyer Essen University Hospital, Germany Germany Disclosures Honoraria for consulting or speaking (last 5 years): Abbott, AbbVie, Abivax, BMS, Boehringer Ingelheim,

More information

Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT

Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT Carol Cantwell Blood Transfusion Laboratory Manager St Mary s Hospital, ICHNT History Why is blood transfusion involved? What tests are performed in blood transfusion and why? What does a protocol look

More information

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat

More information

MUD SCT. Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University

MUD SCT. Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University MUD SCT Pimjai Niparuck Division of Hematology, Department of Medicine Ramathibodi Hospital, Mahidol University Outlines Optimal match criteria for unrelated adult donors Role of ATG in MUD-SCT Post-transplant

More information

Better Training for Safer Food BTSF

Better Training for Safer Food BTSF Better Training for Safer Food BTSF Programme Animal Health Prevention and Control of Emerging Animal Diseases The One Health concept etienne.thiry@ulg.ac.be One world, One medicine, one One medicine,

More information

Bible Class: Hepatitis B Virus Infection

Bible Class: Hepatitis B Virus Infection Bible Class: Hepatitis B Virus Infection Nasser Semmo UVCM, Hepatology What is the HBV prevalence? 2 Hepatitis B Worldwide approx. 350 Mio. chronically infected with HBV Approx. 40% of the world population:

More information

Rama Nada. - Malik

Rama Nada. - Malik - 2 - Rama Nada - - Malik 1 P a g e We talked about HAV in the previous lecture, now we ll continue the remaining types.. Hepatitis E It s similar to virus that infect swine, so its most likely infect

More information

Hepatitis Serology and Background Notes

Hepatitis Serology and Background Notes Hepatitis Serology and Background Notes Updated and presented by David Dickeson 2012 Collated by Evelyn Crewe 2010 Centre for Infectious Diseases & Microbiology Laboratory Services Institute of Clinical

More information

ACTIVITY DISCLAIMER. Kurt Cook, MD, MSc DISCLOSURE. Audience Engagement System. Learning Objectives

ACTIVITY DISCLAIMER. Kurt Cook, MD, MSc DISCLOSURE. Audience Engagement System. Learning Objectives On the Liver Disease Front Lines: Hepatitis A, B and C Prevention and Treatment Kurt Cook, MD, MSc ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family

More information

Emerging TTIs How Singapore secure its blood supply

Emerging TTIs How Singapore secure its blood supply Emerging TTIs How Singapore secure its blood supply Ms Sally Lam Acting Division Director I Blood Supply Management I Blood Services Group I Health Sciences Outline Risk Mitigation Strategies to secure

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091650 Age 49 Years Gender Male 29/8/2017 120000AM 29/8/2017 100248AM 29/8/2017 105306AM Ref By Final HEATITIS, VIRAL, COMREHENSIVE ANEL HEATITIS A ANTIBODY (ANTI

More information

Hepatitis. Epidemiology and Prevention of Viral Hepatitis A, B, and C:

Hepatitis. Epidemiology and Prevention of Viral Hepatitis A, B, and C: Epidemiology and Prevention of Viral Hepatitis A, B, and C: An Overview Andrea L. Cox, M.D., Ph.D. The Viral Hepatitis Center The Johns Hopkins University Hepatitis Inflammation of the liver Can be caused

More information

Diagnosis of CMV infection UPDATE ECIL

Diagnosis of CMV infection UPDATE ECIL UPDATE ECIL-4 2011 Recommendations for CMV and HHV-6 management in patients with hematological diseases Per Ljungman, Rafael de la Camara, Hermann Einsele, Dan Engelhard, Pierre Reusser, Jan Styczynski,

More information

HEV Assay Development Update

HEV Assay Development Update HEV Assay Development Update Jeffrey M. Linnen, Ph.D. Senior Director, Research & Development Hologic Gen-Probe, San Diego, California USA IPFA/PEI 20th International Workshop on Surveillance and Screening

More information

SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM

SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN SECTION 2: OLYSIO with (PEGINTRON) AND RIBAVIRIN RATIONALE FOR INCLUSION IN PA PROGRAM SECTION 1: OLYSIO with (PEGASYS) AND RIBAVIRIN Background Hepatitis

More information

AML:Transplant or ChemoTherapy?

AML:Transplant or ChemoTherapy? AML:Transplant or ChemoTherapy? 1960 s: Importance of HLA type in Animal Models Survival of Dogs Given 1000 RAD TBI and a Marrow Infusion from a Littermate Matched or Mismatched for Dog Leucocyte Antigens

More information

Recommendations for VZV management in. Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman

Recommendations for VZV management in. Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman Recommendations for VZV management in patients Cas cliniques with leukemia Dan Engelhard, Pierre Reusser, Rafael de la Camara, Hermann Einsele, Jan Styczynski, Kate Ward, Per Ljungman Introduction Acute

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091608 Age 26 Years Gender Female 30/8/2017 92900AM 30/8/2017 94717AM 31/8/2017 90216AM Ref By Final HEATITIS ACUTE VIRUS CONFIRMATION HEATITIS A ANTIBODY (ANTI HAV),

More information

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy

NHS Greater Glasgow & Clyde SOP No. BMT Haemopoietic Stem Cell Transplantation Services Vaccination Policy This policy was written with advice from Dr S Ahmed, Consultant in Public Health, Greater Glasgow & Clyde. We would like to thank him for his guidance. 1. Background It is recommended by EBMT and CDC that

More information

ESCCMID OLL. by Author. Hepatitis in immunocompromised hosts. Treviso, July 5, Saverio G Parisi

ESCCMID OLL. by Author. Hepatitis in immunocompromised hosts. Treviso, July 5, Saverio G Parisi Hepatitis in immunocompromised hosts Treviso, July 5, 2011 Saverio G Parisi Department of Histology, Microbiology and Medical Biotechnology Università di Padova HBV Virological categories Persistent HBV

More information

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems: National capabilities in public health systems Indonesia

More information

Need for Chronic Viral Hepatitis Monitoring System

Need for Chronic Viral Hepatitis Monitoring System Need for Chronic Viral Hepatitis Monitoring System Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands Rotterdam November 2008 National

More information

Screening and Diagnosis of Hepatitis Virus Infections

Screening and Diagnosis of Hepatitis Virus Infections Screening and Diagnosis of Hepatitis Virus Infections Prof. Jean-Michel Pawlotsky, MD, PhD National Reference Center for Viral Hepatitis B, C and delta Department of Virology & INSERM U955 Henri Mondor

More information

Hepatitis C (Hep C) By Joshua Rollins. Transmission/Reservoirs

Hepatitis C (Hep C) By Joshua Rollins. Transmission/Reservoirs Hepatitis C (Hep C) By Joshua Rollins Etiological Agent: Hepatitis C virus (HCV) Transmission/Reservoirs Reservoir: Human The infection stems from the Hepatitis C virus (HCV), which is Blood borne pathogen

More information

COURSE DESCRIPTION. Copyright Information

COURSE DESCRIPTION. Copyright Information COURSE DESCRIPTION This continuing education course will review six types of hepatitis: Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, and Hepatitis G. Information about symptoms, diagnosis,

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

Vaccines in Immunocompromised hosts

Vaccines in Immunocompromised hosts Vaccines in Immunocompromised hosts Carlos del Rio, MD Emory Center for AIDS Research October 2013 Immunocompromised hosts Number has increased rapidly in the past decades Broad term that encompasses different

More information

Le infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy

Le infezioni fungine nel trapianto di cellule staminali emopoietiche. Claudio Viscoli Professor of Infectious Disease University of Genova, Italy Le infezioni fungine nel trapianto di cellule staminali emopoietiche Claudio Viscoli Professor of Infectious Disease University of Genova, Italy Potential conflicts of interest Received grants as speaker/moderator

More information